Metabolic consequences of 5-year growth hormone (GH) therapy in children treated with GH for idiopathic short stature. Genentech Collaborative Study Group.

Saenger, P; Attie, K M; DiMartino-Nardi, J; Hintz, R; Frahm, L; Frane, J W

Saenger, P; Attie, K M; DiMartino-Nardi, J; Hintz, R; Frahm, L; Frane, J W.

Affiliation

Saenger P; Department of Pediatrics, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York 10467, USA.

J Clin Endocrinol Metab ; 83(9): 3115-20, 1998 Sep.

Article in En | MEDLINE | ID: mdl-9745413

Subject(s)

Body Height; Human Growth Hormone/therapeutic use; Adolescent; Blood Glucose/metabolism; Child; Cholesterol/blood; Fasting; Female; Food; Glycated Hemoglobin/metabolism; Human Growth Hormone/administration & dosage; Humans; Insulin/blood; Insulin-Like Growth Factor I/metabolism; Male; Thyroxine/blood; Triglycerides/blood

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Body Height / Human Growth Hormone Type of study: Clinical_trials / Guideline Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: J Clin Endocrinol Metab Year: 1998 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links